Jump to
01
Perimenopause is a time of transition, marked by fluctuating hormones and a host of symptoms—mood swings, anxiety, poor sleep, and hot flushes. While many women seek natural treatments, saffron (Crocus sativus L.) has emerged as a scientifically validated option. Recent clinical research confirms its ability to support mood, anxiety, and sleep, making it a valuable tool for perimenopausal women.
Let’s explore the health benefits of saffron, the science behind its effects, and how Affron®, the most clinically studied saffron extract, provides targeted relief for perimenopausal symptoms.
%end section%
02
The Proven Health Benefits of Saffron
Saffron, known as the “golden spice,” has been prized for centuries for its medicinal properties. Derived from the flower petals of Crocus sativus, saffron contains bioactive compounds such as crocin, safranal, and picrocrocin, which contribute to its antioxidant, anti-inflammatory, and neuroprotective effects.(1)
The growing interest in saffron for mental well-being is backed by research exploring its potential to support mood stability, stress resilience, and sleep quality.(2)
Mood and Emotional Balance
During perimenopause, fluctuating estrogen and progesterone levels can affect neurotransmitters like serotonin and dopamine, leading to shifts in mood.
A randomised controlled trial found that saffron supplementation was associated with improvements in mood and anxiety levels, with effects comparable to some pharmaceutical antidepressants.(2)
Another study reported that saffron may help with mild anxiety and stress, supporting a sense of emotional balance.(1)
While more research is needed, these findings suggest saffron could be a valuable addition to a holistic approach to perimenopausal well-being.
Saffron’s Role in Sleep Quality
Sleep disturbances are one of the most common concerns during perimenopause. Whether it’s difficulty falling asleep or waking up in the middle of the night, disrupted sleep can have a ripple effect on energy, mood, and overall health.
Emerging research suggests that saffron may support sleep quality by:
- Modulating serotonin and GABA levels, which help regulate sleep cycles.
- Promoting relaxation, potentially easing the transition into restful sleep.
- Reducing stress-related cortisol spikes, which can interfere with deep sleep.
A 12-week placebo-controlled study found that women taking saffron reported improvements in sleep quality and duration(2).
%end section%
03
Affron® – The Clinically Proven Saffron Extract for Perimenopause
Not all saffron supplements are created equal. Affron® is a patented saffron extract that has undergone placebo-controlled clinical trials to confirm its benefits for perimenopausal women.
A 12-week Australian study on perimenopausal women found that 85% experienced improved mood, characterised by a 33% reduction in average anxiety scores and a 32% reduction in average depression scores from baseline.(2)
Affron® stands out because it is:
- Clinically validated in multiple randomised clinical trials
- Standardised for bioactive compounds
- Backed by strong scientific evidence

%end section%
04
How to Incorporate Saffron Into Your Daily Routine
Saffron Supplements vs. Dietary Sources
While saffron can be consumed in savoury dishes, saffron tea, or saffron powder, therapeutic effects require consistent saffron supplementation in clinically studied doses.
- Recommended dosage: 28–30 mg per day.(1)
- Safety considerations: Saffron is well tolerated but should be used cautiously in individuals on blood pressure medication.
Meno Essential +: A Science-Backed Solution for Menopause
Biolae’s Meno Essential + is a practitioner-formulated blend that combines Affron® with other clinically tested natural ingredients to treat menopause symptoms at their source.
Meno Essential + contains:
- Affron® – Clinically proven to improve mood, reduce anxiety, and enhance sleep quality.
- Lifenol® – A patented phytoestrogen from hops that targets hot flushes and night sweats.
- Chasteberry (Vitex agnus-castus) – A traditional herbal remedy that supports hormonal balance and reduces mood fluctuations.
- P5P (Pyridoxal-5-Phosphate) – The active form of Vitamin B6, essential for neurotransmitter synthesis and hormonal regulation.
By combining these powerful ingredients, Meno Essential + offers comprehensive relief for perimenopausal women experiencing hot flushes, night sweats, mood instability, and poor sleep.
%end section%
05
The Future of Saffron Research in Women’s Health
Saffron is gaining attention as a natural therapy for hormonal and neurological health. Though more research is needed to be conclusive, emerging research is investigating saffron’s ability to:
- Improve insulin sensitivity, reducing the risk of type 2 diabetes.
- Support heart health by lowering LDL cholesterol and addressing heart disease risk factors.
- Enhance cognitive function in patients with mild to moderate depression and age-related macular degeneration.
With ongoing randomised clinical trials, the potential for saffron in menopause, mental health, and chronic diseases is expanding.
%end section%
06
Takeaways
The research is clear—saffron’s health benefits extend beyond its culinary use, offering anti-inflammatory, antioxidant, and neuroprotective properties that support mental health, sleep quality, and hormonal balance.
For perimenopausal women, Affron® provides the most clinically validated saffron therapy, with significant improvements in mood, anxiety, and sleep. As part of Meno Essential +, it combines with Lifenol®, Chasteberry, and P5P for comprehensive menopause support.
Saffron supplementation is a powerful, evidence-based way to ease the transition through perimenopause—naturally.
References:
*affron® is a registered trademark of Pharmactive Biotech Products, S.L.U.
- Lopresti AL, Drummond PD. Saffron supplementation in the treatment of major depressive disorder: A randomized, double-blind, placebo-controlled trial. J Affect Disord. 2017; PMID: 28735826.
- Marx W, Lane M, Rocks T, et al. Effect of saffron extract on symptoms of anxiety and depression in perimenopausal women: A 12-week randomized, double-blind, placebo-controlled trial. J Affect Disord. 2021; PMID: 34463070.